HeadWise HeadWise: Volume 6, Issue 2 | Page 12

BOTOXChronicMigraine . com

DON ’ T LIE DOWN

STAND UP

TO CHRONIC MIGRAINE

For adults with Chronic Migraine
For adults with Chronic Migraine , 15 or more headache days a month , each lasting 4 hours or more
BOTOX ® prevents on average 8 to 9 headache days and migraine / probable migraine days a month ( versus 6 to 7 for placebo ). BOTOX ® is not approved for adults with migraine who have 14 or fewer headache days a month .
Talk to a headache specialist Go online for more information and to learn about savings
BOTOX ® is the first and only FDA-approved preventive treatment for Chronic Migraine
● BOTOX ® is proven to prevent headaches before they even start
● BOTOX ® is shown to prevent migraines before they even start
● BOTOX ® is injected by a doctor once every 12 weeks
● BOTOX ® is covered by most insurance companies

BOTOXChronicMigraine . com

INDICATION
BOTOX ® is a prescription medicine that is injected to prevent headaches in adults with chronic migraine who have 15 or more days each month with headache lasting 4 or more hours each day in people 18 years or older .
It is not known whether BOTOX ® is safe or effective to prevent headaches in patients with migraine who have 14 or fewer headache days each month ( episodic migraine ).
IMPORTANT SAFETY INFORMATION
BOTOX ® may cause serious side effects that can be life threatening . Get medical help right away if you have any of these problems any time ( hours to weeks ) after injection of BOTOX ®:
● Problems swallowing , speaking , or breathing , due to weakening of associated muscles , can be severe and result in loss of life . You are at the highest risk if these problems are pre-existing before injection . Swallowing problems may last for several months .
Please see additional Important Safety Information on adjacent page .
● Spread of toxin effects . The effect of botulinum toxin may affect areas away from the injection site and cause serious symptoms including : loss of strength and all-over muscle weakness , double vision , blurred vision and drooping eyelids , hoarseness or change or loss of voice , trouble saying words clearly , loss of bladder control , trouble breathing , trouble swallowing .
© 2016 Allergan , Inc ., Irvine , CA 92612 . ® marks owned by Allergan , Inc . Dysport is a registered trademark of Ipsen Biopharm Limited Company . Myobloc is a registered trademark of Solstice Neurosciences , Inc . Xeomin is a registered trademark of Merz Pharma GmbH & Co KGaA . APC24HN16
12 HeadWise ® | Volume 6 , Issue 2 • 2016